Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects
- PMID: 37087816
- PMCID: PMC10182388
- DOI: 10.1016/j.ymgme.2023.107582
Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects
Abstract
Immunological problems are increasingly acknowledged manifestations in many inherited metabolic diseases (IMDs), ranging from exaggerated inflammation, autoimmunity and abnormal cell counts to recurrent microbial infections. A subgroup of IMDs, the congenital disorders of glycosylation (CDG), includes CDG types that are even classified as primary immunodeficiencies. Here, we reviewed the list of metabolic disorders reported to be associated with various immunological defects and identified 171 IMDs accompanied by immunological manifestations. Most IMDs are accompanied by immune dysfunctions of which immunodeficiency and infections, innate immune defects, and autoimmunity are the most common abnormalities reported in 144/171 (84%), 44/171 (26%) and 33/171 (19%) of IMDs with immune system involvement, respectively, followed by autoinflammation 17/171 (10%). This article belongs to a series aiming at creating and maintaining a comprehensive list of clinical and metabolic differential diagnoses according to organ system involvement.
Keywords: Autoimmunity; Immune defect; Immunodeficiency; Inherited metabolic disorders.
Published by Elsevier Inc.
Figures

Similar articles
-
Clinical and biochemical footprints of inherited metabolic diseases: Ia. Movement disorders, updated.Mol Genet Metab. 2025 May;145(1):109084. doi: 10.1016/j.ymgme.2025.109084. Epub 2025 Mar 18. Mol Genet Metab. 2025. PMID: 40132382 Review.
-
Clinical and biochemical footprints of inherited metabolic disorders. VII. Ocular phenotypes.Mol Genet Metab. 2022 Apr;135(4):311-319. doi: 10.1016/j.ymgme.2022.02.002. Epub 2022 Feb 15. Mol Genet Metab. 2022. PMID: 35227579 Free PMC article. Review.
-
Clinical and biochemical footprints of inherited metabolic diseases. IX. Metabolic ear disease.Mol Genet Metab. 2022 Nov;137(3):223-229. doi: 10.1016/j.ymgme.2022.09.005. Epub 2022 Sep 23. Mol Genet Metab. 2022. PMID: 36183456 Free PMC article. Review.
-
Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms.Mol Genet Metab. 2023 Mar;138(3):107528. doi: 10.1016/j.ymgme.2023.107528. Epub 2023 Feb 1. Mol Genet Metab. 2023. PMID: 36774919 Free PMC article. Review.
-
Clinical and biochemical footprints of inherited metabolic disease. XVI. Hematological abnormalities.Mol Genet Metab. 2023 Dec;140(4):107735. doi: 10.1016/j.ymgme.2023.107735. Epub 2023 Nov 13. Mol Genet Metab. 2023. PMID: 37989003 Free PMC article. Review.
Cited by
-
The Reciprocal Interplay between Infections and Inherited Metabolic Disorders.Microorganisms. 2023 Oct 12;11(10):2545. doi: 10.3390/microorganisms11102545. Microorganisms. 2023. PMID: 37894204 Free PMC article. Review.
-
Congenital disorders of glycosylation with multiorgan disruption and immune dysregulation caused by compound heterozygous variants in MAN2B2.Mol Genet Genomic Med. 2024 Apr;12(4):e2422. doi: 10.1002/mgg3.2422. Mol Genet Genomic Med. 2024. PMID: 38622837 Free PMC article.
-
Clinical and biochemical footprints of inherited metabolic diseases. XIII. Respiratory manifestations.Mol Genet Metab. 2023 Nov;140(3):107655. doi: 10.1016/j.ymgme.2023.107655. Epub 2023 Jul 24. Mol Genet Metab. 2023. PMID: 37517329 Free PMC article. Review.
-
Clinical and biochemical footprints of inherited metabolic diseases. XIV. Metabolic kidney diseases.Mol Genet Metab. 2023 Nov;140(3):107683. doi: 10.1016/j.ymgme.2023.107683. Epub 2023 Aug 12. Mol Genet Metab. 2023. PMID: 37597335 Free PMC article.
-
Delivering the Message: Translating mRNA Therapy for Liver Inherited Metabolic Diseases.J Inherit Metab Dis. 2025 Sep;48(5):e70078. doi: 10.1002/jimd.70078. J Inherit Metab Dis. 2025. PMID: 40826824 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical